Human hypertrophic and keloid scar models: principles, limitations and future challenges from a tissue engineering perspective
about
Microencapsulated equine mesenchymal stromal cells promote cutaneous wound healing in vitroIngenol mebutate treatment in keloidsKeloids and Hypertrophic Scars: A Spectrum of Clinical Challenges.The Northwestern Abdominoplasty Scar Model: A Novel Human Model for Scar Research and Therapeutics.Dermal Fibroblasts from the Red Duroc Pig Have an Inherently Fibrogenic Phenotype: An In Vitro Model of Fibroproliferative ScarringSorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways.Involvement of eIF6 in external mechanical stretch-mediated murine dermal fibroblast function via TGF-β1 pathway.Abdominal scar characteristics as a predictor of cervical stenosis after abdominal radical trachelectomyTargeted killing of myofibroblasts by biosurfactant di-rhamnolipid suggests a therapy against scar formation.Secreted factors from equine mesenchymal stromal cells diminish the effects of TGF-β1 on equine dermal fibroblasts and alter the phenotype of dermal fibroblasts isolated from cutaneous fibroproliferative wounds.Engineering approaches to study fibrosis in 3-D in vitro systems.Non-animal models of wound healing in cutaneous repair: In silico, in vitro, ex vivo, and in vivo models of wounds and scars in human skin.Development of a Full-Thickness Human Skin Equivalent In Vitro Model Derived from TERT-Immortalized Keratinocytes and Fibroblasts.MicroRNA-21 inhibits mitochondria-mediated apoptosis in keloid.Thermal injury model in the rabbit ear with quantifiable burn progression and hypertrophic scar.A novel model of humanised keloid scarring in mice.How Signaling Molecules Regulate Tumor Microenvironment: Parallels to Wound Repair.Wound regeneration deficit in rats correlates with low morphogenetic potential and distinct transcriptome profile of epidermis.Soft tissue engineering with micronized-gingival connective tissues.Computational analysis identifies putative prognostic biomarkers of pathological scarring in skin wounds.Noninvasive proteome analysis of psoriatic stratum corneum reflects pathophysiological pathways and is useful for drug profiling.Different wound healing properties of dermis, adipose, and gingiva mesenchymal stromal cells.Bottom-up approaches in synthetic biology and biomaterials for tissue engineering applications.Spatiotemporal Evolution of the Wound Repairing Process in a 3D Human Dermis Equivalent.Hypertrophic Scarring in the Rabbit Ear: A Practical Model for Studying Dermal Fibrosis.Where we stand with human hypertrophic and keloid scar models.Suppressed inflammatory gene expression during human hypertrophic scar compared to normotrophic scar formation.Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.Galangin inhibits hypertrophic scar formation via ALK5/Smad2/3 signaling pathway.
P2860
Q28392792-33194061-AE84-46C0-ACE0-99C1BD24900AQ35782496-EC1BC586-027F-4DAE-97F4-D243555A68E4Q35928377-5D3B44FD-816D-44F9-B8F8-5B7C3444BF68Q36167216-656FD329-1FEB-4551-A348-AD072F5DA60CQ36218953-138E6B3C-4E6E-4AEE-9D7B-3616B376E921Q37314221-E04DD2BD-20AF-4BCA-84BE-4B302B0B2592Q37400213-B3589ED1-92B8-48FC-9102-2C4B253B37D0Q37437293-803D77E1-8F9B-4ED7-A96D-09FF983B4E01Q37454142-15C2F35F-DA46-458D-AC5C-A32FFF02A6ABQ38735922-B2265E03-E854-4560-B66F-A007A5A81E52Q38754809-A0774541-EF69-4F48-BACE-D1EE2BC001FCQ38766135-7781D8A1-31F7-45BC-B463-96D3005F69D3Q38857654-26FF6EFF-23DE-4ED2-BC4E-9565FDDF89E2Q44833827-68E07B81-A6C0-43B2-A8BE-9E3B585D1788Q46391194-5DCED288-FD15-424B-A39A-368ED10244DFQ47596215-2C9647B6-CC41-4DC7-8B75-EBE32AF7804FQ47601253-12AC005A-A433-4AC1-9678-B164210DD6EAQ47742231-CEC17A14-421E-43F4-8794-F4560335FF79Q48199421-F7E15D18-2533-4BB0-B566-7C476936D29CQ49842909-70196903-4CCE-4DBC-827C-65AE19D15505Q51165648-CB446D94-5351-4460-B2FB-EB82AD5FA9D0Q51656022-9B42320B-AC31-4B07-9418-AD14EC46A430Q52649385-93A3EA29-1E80-4FF4-8EA1-50FD47FAD1EEQ52881370-854E7291-6C45-4C9B-A83D-2AB45533950FQ53098397-BF393467-ABB7-41CE-BFA3-10E44E9E1444Q53497972-8D499365-63FB-437F-99A8-ECF915F03A33Q53517802-3BC11608-A15A-41DA-A4FB-AA8D682AAF41Q53615839-C9144496-86A0-45B5-B652-C2E180BE07BCQ55032489-27DC3B8A-FDED-4B52-B5AE-4702299F89DF
P2860
Human hypertrophic and keloid scar models: principles, limitations and future challenges from a tissue engineering perspective
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Human hypertrophic and keloid ...... tissue engineering perspective
@ast
Human hypertrophic and keloid ...... tissue engineering perspective
@en
Human hypertrophic and keloid ...... tissue engineering perspective
@nl
type
label
Human hypertrophic and keloid ...... tissue engineering perspective
@ast
Human hypertrophic and keloid ...... tissue engineering perspective
@en
Human hypertrophic and keloid ...... tissue engineering perspective
@nl
prefLabel
Human hypertrophic and keloid ...... tissue engineering perspective
@ast
Human hypertrophic and keloid ...... tissue engineering perspective
@en
Human hypertrophic and keloid ...... tissue engineering perspective
@nl
P2093
P2860
P921
P3181
P356
P1476
Human hypertrophic and keloid ...... tissue engineering perspective
@en
P2093
Frank B Niessen
Lenie J van den Broek
Susan Gibbs
P2860
P304
P3181
P356
10.1111/EXD.12419
P407
P577
2014-06-01T00:00:00Z